Stocks › QGEN

QIAGEN N.V.

QGEN·NYSE·USD
$49.30
-0.33 (-0.66%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
QGEN
QIAGEN N.V. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
QGENS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of QGEN by members of U.S. Congress · 16 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Donna ShalalaDonna ShalalaHouse · D · FL QGENQIAGEN N.V. · Stock Sale
$1,001 - $15,000
Apr 27, 2020 Jan 23, 2019 Filing ↗
Donna ShalalaDonna ShalalaHouse · D · FL QGENQIAGEN N.V. · Stock Sale
$1,001 - $15,000
Apr 27, 2020 Jan 9, 2019 Filing ↗
Peter WelchPeter WelchHouse · D · VT QGENQIAGEN N.V. · Stock Sale
$1,001 - $15,000
Apr 3, 2020 Mar 24, 2020 Filing ↗
Peter WelchPeter WelchHouse · D · VT QGENQIAGEN N.V. · Stock Purchase
$1,001 - $15,000
Mar 10, 2020 Feb 27, 2020 Filing ↗
Alan S. LowenthalAlan S. LowenthalHouse · D · CA QGENQIAGEN N.V. · Stock Sale
$15,001 - $50,000
Nov 8, 2019 Oct 8, 2019 Filing ↗
Alan S. LowenthalAlan S. LowenthalHouse · D · CA QGENQIAGEN N.V. · Stock Sale
$1,001 - $15,000
Nov 8, 2019 Oct 8, 2019 Filing ↗
Alan S. LowenthalAlan S. LowenthalHouse · D · CA QGENQIAGEN N.V. · Stock Sale
$737.20
Nov 7, 2019 Oct 8, 2019 Filing ↗
Alan S. LowenthalAlan S. LowenthalHouse · D · CA QGENQIAGEN N.V. · Stock Purchase
$135.55
Sep 21, 2019 Sep 13, 2019 Filing ↗
Alan S. LowenthalAlan S. LowenthalHouse · D · CA QGENQIAGEN N.V. · Stock Purchase
$168.81
Sep 21, 2019 Sep 12, 2019 Filing ↗
Alan S. LowenthalAlan S. LowenthalHouse · D · CA QGENQIAGEN N.V. · Stock Purchase
$1,001 - $15,000
Sep 21, 2019 Sep 13, 2019 Filing ↗
Alan S. LowenthalAlan S. LowenthalHouse · D · CA QGENQIAGEN N.V. · Stock Purchase
$1,001 - $15,000
Sep 21, 2019 Sep 12, 2019 Filing ↗
Alan S. LowenthalAlan S. LowenthalHouse · D · CA QGENQIAGEN N.V. · Stock Purchase
$1,001 - $15,000
Sep 21, 2019 Sep 13, 2019 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH QGENQIAGEN N.V. · Stock Purchase
$15,001 - $50,000
Sep 21, 2017 Sep 1, 2017 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH QGENQIAGEN N.V. · Stock Purchase
$15,001 - $50,000
Aug 10, 2017 Jul 28, 2017 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH QGENQIAGEN N.V. · Stock Purchase
$15,001 - $50,000
May 18, 2017 May 4, 2017 Filing ↗
Alan S. LowenthalAlan S. LowenthalHouse · D · CA QGENQIAGEN N.V. · Stock Purchase
$1,001 - $15,000
Mar 7, 2017 Feb 28, 2017 Filing ↗

Whale Activity

Position changes in QGEN reported for 2026-09-30 by 399 institutional filers
Increased: 139New: 61Held: 46Decreased: 102Closed: 34No prior filing: 17
  • Increased139
  • New61
  • Held46
  • Decreased102
  • Closed34
  • No prior filing17
FilerSharesValueChange
PRICE T ROWE ASSOCIATES INC /MD/16.4M$719.4Mincreased
WELLINGTON MANAGEMENT GROUP LLP11.6M$509.5Mdecreased
PRINCIPAL FINANCIAL GROUP INC8.4M$367.4M—
VANGUARD CAPITAL MANAGEMENT LLC6.3M$271.9Mincreased
BlackRock, Inc.5.8M$254.1Mdecreased
Fivespan Partners, LP5.4M$237.6Mincreased
GOLDMAN SACHS GROUP INC5.1M$224.1Mincreased
EARNEST PARTNERS LLC4.7M$203.6Mincreased
Amundi4.6M$203.3Mincreased
BANK OF AMERICA CORP /DE/3.8M$165.1Mincreased
DIMENSIONAL FUND ADVISORS LP3.3M$144.9Mincreased
MORGAN STANLEY2.9M$127.9Mdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by QGEN insiders, by quarter · Form 4

No open-market insider buys or sells in the last two years.

Recent Insider Transactions

0 transactions on record · newest first
All insider activity →

No insider transactions on record.

Fund Holders

Mutual funds and ETFs holding QGEN · SEC Form N-PORT
FundSharesValue% of fundAs of
International Equity Fund
Principal Funds, Inc
1.8M$73.1M1.13%Jul 31, 2026
Victory Sycamore Small Company Opportunity Fund
Victory Portfolios
1.0M$39.3M0.84%Jun 30, 2026
iShares Russell 1000 Value ETF
iShares Trust
460.6K$18.0M0.02%Jun 30, 2026
Dimensional International Small Cap ETF
Dimensional ETF Trust
411.2K$17.0M0.30%Jul 31, 2026
Nuveen International Equity Index Fund
TIAA-CREF Funds
326.7K$13.4M0.04%Jul 31, 2026
Dimensional International Core Equity 2 ETF
Dimensional ETF Trust
321.1K$13.3M0.09%Jul 31, 2026
Small-MidCap Dividend Income Fund
Principal Funds, Inc
254.5K$11.0M1.00%Aug 31, 2026
Nuveen Quant Small/Mid Cap Equity Fund
TIAA-CREF Funds
252.3K$10.4M0.39%Jul 31, 2026
College Retirement Equities Fund - Total Global Stock Account
College Retirement Equities Fund
249.8K$9.8M0.01%Jun 30, 2026
Nuveen Equity Index Fund
TIAA-CREF Funds
200.2K$8.3M0.01%Jul 31, 2026

Mutual funds and ETFs whose N-PORT filings list QGEN's shares (CUSIP N72482156), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Wellington Investment Advisors Holdings LLPSCHEDULE 13G/A · passive (13G) · 1.9M shares0.9%
    Nov 6, 2026 · ↗
  • Wellington Group Holdings LLPSCHEDULE 13G/A · passive (13G) · 1.9M shares0.9%
    Nov 6, 2026 · ↗
  • Wellington Management Group LLPSCHEDULE 13G/A · passive (13G) · 1.9M shares0.9%
    Nov 6, 2026 · ↗
  • Massachusetts Financial Services CompanySCHEDULE 13G/A · passive (13G) · 12.4M shares6.0%
    Jun 5, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming qiagen as client

No lobbying filings found naming QIAGEN N.V. as the client.

  • HEALTH AND MEDICINE COUNSEL, LLCQIAGEN, INC. C/O D.FRASER ASSOCIATES, LLC · 2020 Q3 · HCR, BUD—
    Filing ↗
  • HEALTH AND MEDICINE COUNSEL, LLCQIAGEN, INC. C/O D.FRASER ASSOCIATES, LLC · 2020 Q2 · HCR, BUD—
    Filing ↗
  • HEALTH AND MEDICINE COUNSEL, LLCQIAGEN, INC. C/O D.FRASER ASSOCIATES, LLC · 2020 Q1 · HCR, BUD—
    Filing ↗
  • HEALTH AND MEDICINE COUNSEL, LLCQIAGEN, INC. C/O D.FRASER ASSOCIATES, LLC · 2020 Q1 · BUD, HCR—
    Filing ↗
  • HEALTH AND MEDICINE COUNSEL, LLCQIAGEN, INC. C/O D.FRASER ASSOCIATES, LLC · 2019 Q4 · HCR—
    Filing ↗

Government Contracts

Federal awards to qiagen · USAspending
$6.8MAwarded · 84 contracts on record
  • Department of JusticeQIAGEN CONSUMABLES$244K
    Mar 5, 2026 · ↗
  • Department of Health and Human ServicesQCII TRANSLATIONAL 5,000 SAMPLES$16K
    Sep 30, 2020 · ↗
  • Department of Veterans AffairsGENE MUTATION JAK2 CPT$41K
    Oct 1, 2024 · ↗
  • Department of Health and Human ServicesQIAGEN INC:1110297 [21-007704]$28K
    Aug 30, 2021 · ↗
  • Department of Health and Human ServicesQIAGEN INC:1110297 [23-002258]$37K
    Jan 30, 2023 · ↗
  • Department of Health and Human ServicesQIAGEN INC:1110297 [23-013139]$24K
    Aug 29, 2023 · ↗
  • Department of Health and Human ServicesMAINTENANCE AGREEMENT FOR QIASYMPHONY SP, FULL AGREEMENT 9241207$11K
    Aug 17, 2022 · ↗
  • Department of CommerceQIACUBE DNA EXTRACTOR ROBOT SERVICE, REPAIRS, AND CALIBRATION FOR AUKE BAY LABORATORY IN JUNEAU, ALASKA. NOAA APPROVAL #OR-25-01689.$12K
    Jul 14, 2025 · ↗

U.S. Patents

Recent USPTO applications naming QIAGEN N.V.

No USPTO patent applications found for QIAGEN N.V..

Annual Financials

From QGEN's 10-K filings · XBRL

SEC's XBRL figures for QIAGEN N.V. include no full-year results from a 10-K in US dollars, so there is no table to show. Companies based abroad usually report annually on Form 20-F instead.

Stock Splits

Every split and reverse split in the price history
  • 19-for-20Reverse splitJan 8, 2026
  • 30-for-31Reverse splitJan 30, 2024
  • 25-for-26Reverse splitJan 25, 2017
  • 4-for-1Stock splitJul 14, 2000
  • 2-for-1Stock splitJul 16, 1999

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC

No 8-K filings on record.

About QIAGEN N.V.

From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersPL VENLO
IncorporatedP7
Former namesQIAGEN NV